Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q1 2023 Earnings

15MayExpected

Q4 2022

Q1 2023

-1.74

-1.33

-0.92

-0.51

Details

Expected EPS

-0.89

Actual EPS

-0.51

Surprise EPS

0.38

Surprise Percent

+42.7%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -0.51 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.